Recent advances in metabolomics in neurological disease, and future perspectives

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 25, 2013, Pages 8143-8150

  Zhang, Ai Hua ^a   Sun, Hui ^a   Wang, Xi Jun ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Cerebrospinal fluid; Diagnosis; Metabolites; Metabolomics; Neurological diseases

Indexed keywords

BIOCHEMICAL PATHWAY; CEREBRO SPINAL FLUIDS; CLINICAL DIAGNOSTICS; FUTURE PERSPECTIVES; METABOLOMICS; NEUROLOGICAL DISEASE; NEUROLOGICAL DISORDERS; PARKINSON'S DISEASE;

AMINO ACIDS; BIOCHEMISTRY; BRAIN; CEREBROSPINAL FLUID; METABOLITES; MOLECULES; NEURODEGENERATIVE DISEASES; NEUROLOGY;

DIAGNOSIS;

ANIMAL; CEREBROSPINAL FLUID; DEGENERATIVE DISEASE; HUMAN; METABOLISM; METABOLOME; METABOLOMICS; METHODOLOGY; NEUROLOGIC DISEASE; REVIEW;

ANIMALS; HUMANS; METABOLOME; METABOLOMICS; NERVOUS SYSTEM DISEASES; NEURODEGENERATIVE DISEASES;

EID: 84885294949     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-013-7061-4     Document Type: Review

References (80)

1. Nicholson JK, Lindon JC (2008) Systems biology: Metabonomics. Nature 455:1054-1056
2. Zhang A, Sun H, Wang X (2012) Serum metabolomics as a novel diagnostic approach for disease: a systematic review. Anal Bioanal Chem 404(4):1239-45
3. Wang X, Zhang A, Sun H (2013) Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma. Hepatology 57(5):2072-7
4. Sun H, Zhang A, Yan G, Piao C, Li W, Sun C, Wu X, Li X, Chen Y, Wang X (2013) Metabolomic analysis of key regulatory metabolites in hepatitis C virus-infected tree shrews. Mol Cell Proteomics 12(3):710-9
5. Yuan M, Breitkopf SB, Yang X, Asara JM (2012) A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc 7:872-881
6. Zhang A, Sun H, Han Y, Yuan Y, Wang P, Song G, Yuan X, Zhang M, Xie N, Wang X (2012) Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach. Analyst 137(18):4200-8
7. Wang X, Zhang A, Wang P, Sun H, Wu G, Sun W, Lv H, Jiao G, Xu H, Yuan Y, Liu L, Zou D, Wu Z, Han Y, Yan G, Dong W, Wu F, Dong T, Yu Y, Zhang S, Wu X, Tong X, Meng X (2013) Metabolomics coupled with proteomics advancing drug discovery towards more agile development of targeted combination therapies, Mol Cell Proteomics. doi: 10.1074/mcp.M112.021683
8. Noga MJ, Dane A, Shi S, Attali A, van Aken H, Suidgeest E, Tuinstra T, Muilwijk B, Coulier L, Luider T, Reijmers TH, Vreeken RJ, Hankemeier T (2012) Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis. Metabolomics 8:253-263
9. Hassan-Smith G, Wallace GR, Sinclair AJ (2012) The role of metabolomics in neurological disease. J Neuroimmunol, Douglas MR. doi: 10.1016/j.jneuroim. 2012.01.009
10. Lutz NW, Cozzone PJ (2011) Metabolic profiling in multiple sclerosis and other disorders by quantitative analysis of cerebrospinal fluid using nuclear magnetic resonance spectroscopy. Curr Pharm Biotechnol 12(7):1016-25
11. Ibáñez C, Simó C, Martín-Álvarez PJ, Kivipelto M, Winblad B, Cedazo-Mínguez A, Cifuentes A (2012) Toward a predictive model of Alzheimer's disease progression using capillary electrophoresis-mass spectrometry metabolomics. Anal Chem 84(20):8532-40
12. Wang X, Yang B, Sun H, Zhang A (2012) Pattern recognition approaches and computational systems tools for ultra performance liquid chromatography-mass spectrometry-based comprehensive metabolomic profiling and pathways analysis of biological data sets. Anal Chem 84:428-439
13. Hnatyshyn S, Shipkova P (2012) Automated and unbiased analysis of LC-MS metabolomic data. Bioanalysis 4(5):541-54
14. Danielsson AP, Moritz T, Mulder H, Spégel P (2010) Development and optimization of a metabolomic method for analysis of adherent cell cultures. Anal Biochem 404(1):30-9
15. Wang X, Zhang A, Han Y, Wang P, Sun H, Song G, Dong T, Yuan Y, Yuan X, Zhang M, Xie N, Zhang H, Dong H, Dong W (2012) Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Mol Cell Proteomics 11(8):370-80
16. Vineis P, Khan AE, Vlaanderen J, Vermeulen R (2003) The impact of new research technologies on our understanding of environmental causes of disease: the concept of clinical vulnerability. Environ Health 8:54
17. Workentine ML, Harrison JJ, Weljie AM, Tran VA, Stenroos PU, Tremaroli V, Vogel HJ, Ceri H, Turner RJ (2010) Phenotypic and metabolic profiling of colony morphology variants evolved from Pseudomonas fluorescens biofilms. Environ Microbiol 12:1565-1577
18. Nicholson JK, Lindon JC, Holmes E (1999) 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181-1189
19. Hines A, Staff FJ, Widdows J, Compton RM, Falciani F, Viant MR (2010) Discovery of metabolic signatures for predicting whole organism toxicology. Toxicol Sci 115:369-378
20. Wang J, Reijmers T, Chen L, Van Der Heijden R, Wang M, Peng S, Hankemeier T, Xu G, Van Der Greef J (2009) Systems toxicology study of doxorubicin on rats using ultra performance liquid chromatography coupled with mass spectrometry based metabolomics. Metabolomics 5:407-418
21. Johansson-Persson A, Barri T, Ulmius M, Onning G, Dragsted LO (2013) LC-QTOF/MS metabolomic profiles in human plasma after a 5-week high dietary fiber intake. Anal Bioanal Chem 405(14):4799-809
22. Astle J, Ferguson JT, German JB, Harrigan GG, Kelleher NL, Kodadek T, Parks BA, Roth MJ, Singletary KW, Wenger CD, Mahady GB (2007) Characterization of proteomic and metabolomic responses to dietary factors and supplements. J Nutr 137:2787-2793
23. Lee R, West D, Phillips SM, Britz-McKibbin P (2010) Differential metabolomics for quantitative assessment of oxidative stress with strenuous exercise and nutritional intervention: thiol-specific regulation of cellular metabolism with N-acetyl-L-cysteine pretreatment. Anal Chem 82:2959-2968
24. Urakami K, Zangiacomi V, Yamaguchi K, Kusuhara M (2010) Quantitative metabolome profiling of Illicium anisatum by capillary electrophoresis time-of-flight mass spectrometry. Biomed Res 31:161-163
25. Tohge T, Fernie AR (2010) Combining genetic diversity, informatics and metabolomics to facilitate annotation of plant gene function. Nat Protoc 5:1210-1227
26. Pluskal T, Nakamura T, Villar-Briones A, Yanagida M (2010) Metabolic profiling of the fission yeast S. pombe: quantification of compounds under different temperatures and genetic perturbation. Mol Biosyst 6:182-198
27. Clayton TA, Lindon JC, Cloarec O, Antti H, Charuel C, Hanton G, Provost JP, Le Net JL, Baker D, Walley RJ, Everett JR, Nicholson JK (2006) Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440:1073-1077
28. Nomura DK, Dix MM, Cravatt BF (2010) Activity-based protein profiling for biochemical pathway discovery in cancer. Nat Rev Cancer 10:630-638
29. Bathen TF, Geurts B, Sitter B, Fjøsne HE, Lundgren S, Buydens LM, Gribbestad IS, Postma G, Giskeødegård GF (2013) Feasibility of MR Metabolomics for Immediate Analysis of Resection Margins during Breast Cancer Surgery. PLoS One 8(4):e61578
30. Holmes E, Loo RL, Stamler J, Bictash M, Yap IK, Chan Q, Ebbels T, De Iorio M, Brown IJ, Veselkov KA, Daviglus ML, Kesteloot H, Ueshima H, Zhao L, Nicholson JK (2008) P Elliott. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453:396-401
31. Mal M, Koh PK, Cheah PY, Chan EC (2012) Metabotyping of human colorectal cancer using two-dimensional gas chromatography mass spectrometry. Anal Bioanal Chem 403(2):483-93
32. Zhang A, Sun H, Yan G, Han Y, Ye Y, Wang X (2013) Urinary metabolic profiling identifies a key role for glycocholic acid in human liver cancer by ultra-performance liquid-chromatography coupled with high-definition mass spectrometry. Clin Chim Acta 418:86-90
33. Wang H, Ma C, Ma L, Du Z, Wang H, Ye H, Li G, Liu B, Xu G (2009) Secondary metabolic profiling and artemisinin biosynthesis of two genotypes of Artemisia annua. Planta Med 75:1625-1633
34. Fukushima A, Kusano M, Nakamichi N, Kobayashi M, Hayashi N, Sakakibara H, Mizuno T, Saito K (2009) Impact of clock-associated Arabidopsis pseudo-response regulators in metabolic coordination. Proc Natl Acad Sci USA 106:7251-7256
35. Catchpole GS, Beckmann M, Enot DP, Mondhe M, Zywicki B, Taylor J, Hardy N, Smith A, King RD, Kell DB, Fiehn O, Draper J (2009) Hierarchical metabolomics demonstrates substantial compositional similarity between genetically modified and conventional potato crops. Proc Natl Acad Sci USA 102:14458-14462
36. Zhang A, Sun H, Wang X (2012) Power of metabolomics in biomarker discovery and mining mechanisms of obesity, Obes Rev. doi: 10.1111/obr.12011
37. Connor SC, Hansen MK, Corner A, Smith RF, Ryan TE (2010) Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes. Mol Biosyst 6:909-921
38. Zhang A, Sun H, Wang P, Han Y, Wang X (2012) Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach. Complement Ther Med 20(1-2):93-9
39. Zhang A, Sun H, Wang P, Han Y, Wang X (2012) Recent and potential developments of biofluid analyses in metabolomics. J Proteomics 75(4):1079-88
40. Kim HK, Wilson EG, Choi YH, Verpoorte R (2010) Metabolomics: a tool for anticancer lead-finding from natural products. Planta Med 76:1094-1102
41. Zhang A, Sun H, Wang Z, Sun W, Wang P, Wang X (2010) Metabolomics: towards understanding traditional Chinese medicine. Planta Med 76:2026-2035
42. Wang X, Sun H, Zhang A, Sun W, Wang P, Wang Z (2010) Potential role of metabolomics approaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine. J Pharm Biomed Anal 55:859-868
43. Hankemeier T, van Gool AJ, Luider TM, Bischoff R (2011) The impact of delayed storage on the measured proteome and metabolome of human cerebrospinal fluid. Clin Chem 57(12):1703-11
44. Zhang A, Sun H, Wang P, Han Y, Wang X (2012) Modern analytical techniques in metabolomics analysis. Analyst 137(2):293-300
45. Wang X, Sun H, Zhang A, Wang P, Han Y (2011) Ultra-performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studies. J Sep Sci 34:3451-3459
46. Yang B, Zhang A, Sun H, Dong W, Yan G, Li T, Wang X (2012) Metabolomic study of insomnia and intervention effects of Suanzaoren decoction using ultra-performance liquid-chromatography/electrospray- ionization synapt high- definition mass spectrometry. J Pharm Biomed Anal 58:113-124
47. Wang X, Wang H, Zhang A, Lu X, Sun H, Dong H, Wang P (2012) Metabolomics study on the toxicity of aconite root and its processed products using ultraperformance liquid-chromatography/electrospray- ionization synapt high-definition mass spectrometry coupled with pattern recognition approach and ingenuity pathways analysis. J Proteome Res 11:1284-1301
48. Zhang A, Sun H, Wang P, Han Y, Wang X (2012) Metabonomics for discovering biomarkers of hepatotoxicity and nephrotoxicity. Pharmazie 67:99-105
49. Sun H, Zhang A, Wang X (2012) Potential Role of Metabolomic Approaches for Chinese Medicine Syndromes and Herbal Medicine, Phytother Res. doi: 10.1002/ptr.4613
50. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457:910-914
51. Tjalsma H (2010) Identification of biomarkers for colorectal cancer through proteomics-based approaches. Expert Rev Proteomics 7(6):879-95
52. Dong H, Zhang A, Sun H, Wang H, Lu X, Wang M, Ni B, Wang X (2012) Ingenuity pathways analysis of urine metabolomics phenotypes toxicity of Chuanwu in Wistar rats by UPLC-Q-TOF-HDMS coupled with pattern recognition methods. Mol Biosyst 8:1206-1221
53. Denkert C, Bucher E, Hilvo M, Salek R, Orešč M, Griffin J, Brockmöller S, Klauschen F, Loibl S, Barupal DK, Budczies J, Iljin K, Nekljudova V, Fiehn O (2012) Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery. Genome Med 4:37
54. Mandal R, Guo AC, Chaudhary KK, Liu P, Yallou FS, Dong E, Aziat F, Wishart DS (2012) Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update. Genome Med 4(4):38
55. Rosenling T, Slim CL, Christin C, Coulier L, Shi S, Stoop MP, Bosman J, Suits F, Horvatovich PL, Stockhofe-Zurwieden N, Vreeken R, Hankemeier T, van Gool AJ, Luider TM, Bischoff R (2009) The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF). J Proteome Res 8(12):5511-5522
56. Crews B, Wikoff WR, Patti GJ, Woo HK, Kalisiak E, Heideker J, Siuzdak G (2009) Variability analysis of human plasma and cerebral spinal fluid reveals statistical significance of changes in mass spectrometry-based metabolomics data. Anal Chem 81(20):8538-8544
57. Meyer H, Liebeke M, Lalk M (2010) A protocol for the investigation of the intracellular Staphylococcus aureus metabolome. Anal Biochem 401(2):250-9
58. Goodpaster AM, Romick-Rosendale LE, Kennedy MA (2010) Statistical significance analysis of nuclear magnetic resonance-based metabonomics data. Anal Biochem 401(1):134-43
59. Dunn WB, Goodacre R, Neyses L, Mamas M (2011) Integration of metabolomics in heart disease and diabetes research: current achievements and future outlook. Bioanalysis 3(19):2205-22
60. Stoop MP, Coulier L, Rosenling T, Shi S, Smolinska AM, Buydens L, Ampt K, Stingl C, Dane A, Muilwijk B, Luitwieler RL, Sillevis Smitt PA, Hintzen RQ, Bischoff R, Wijmenga SS, Hankemeier T, van Gool AJ, Luider TM (2010) Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples. Mol Cell Proteomics 9(9):2063-2075
61. Smolinska A, Posma JM, Blanchet L, Ampt KA, Attali A, Tuinstra T, Luider T, Doskocz M, Michiels PJ, Girard FC, Buydens LM, Wijmenga SS (2012) Simultaneous analysis of plasma and CSF by NMR and hierarchical models fusion. Anal Bioanal Chem 403(4):947-959
62. Blanchet L, Smolinska A, Attali A, Stoop MP, Ampt KA, van Aken H, Suidgeest E, Tuinstra T, Wijmenga SS, Luider T, Buydens LM (2011) Fusion of metabolomics and proteomics data for biomarkers discovery: case study on the experimental autoimmune encephalomyelitis. BMC Bioinformatics 12:254
63. Bowser R, Cudkowicz M, Kaddurah-Daouk R (2006) Biomarkers for amyotrophic lateral sclerosis. Expert Rev Mol Diagn 6(3):387-398
64. Pradat PF, Dib M (2009) Biomarkers in amyotrophic lateral sclerosis: facts and future horizons. Mol Diagn Ther 13(2):115-25. doi: 10.2165/01250444-200913020-00005
65. Wuolikainen A, Andersen PM, Moritz T, Marklund SL, Antti H (2012) ALS patients with mutations in the SOD1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutations. Mol Genet Metab 105(3):472-478
66. Wuolikainen A, Moritz T, Marklund SL, Antti H, Andersen PM (2011) Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS. PLoS One 6(4):e17947
67. Blasco H, Corcia P, Moreau C, Veau S, Fournier C, Vourc'h P, Emond P, Gordon P, Pradat PF, Praline J, Devos D, Nadal-Desbarats L, Andres CR (2010) 1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis. PLoS One 5(10):e13223
68. Shi M, Huber BR, Zhang J (2010) Biomarkers for cognitive impairment in Parkinson disease. Brain Pathol 20(3):660-671
69. Marek K, Jennings D, Tamagnan G, Seibyl J (2008) Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression. Ann Neurol 64(Suppl 2):S111-21
70. Morgan JC, Mehta SH, Sethi KD (2010) Biomarkers in Parkinson's disease. Curr Neurol Neurosci Rep 10(6):423-430
71. Mellick GD, Silburn PA, Sutherland GT, Siebert GA (2010) Exploiting the potential of molecular profiling in Parkinson's disease: current practice and future probabilities. Expert Rev Mol Diagn 10(8):1035-1050
72. Locasale JW, Melman T, Song S, Yang X, Swanson KD, Cantley LC, Wong ET, Asara JM (2012) Metabolomics of Human Cerebrospinal Fluid Identifies Signatures of Malignant Glioma, Mol Cell Proteomics. doi: 10.1074/mcp.M111.014688mcp.M111. 014688
73. Orešič M, Lötjönen J, Soininen H (2010) Systems medicine and the integration of bioinformatic tools for the diagnosis of Alzheimer's disease. Genome Med 2(11):83
74. Kaddurah-Daouk R, Rozen S, Matson W, Han X, Hulette CM, Burke JR, Doraiswamy PM, Welsh-Bohmer KA (2011) Metabolomic changes in autopsy-confirmed Alzheimer's disease. Alzheimers Dement 7(3):309-317
75. Himmelreich U, Malik R, Kühn T, Daniel HM, Somorjai RL, Dolenko B, Sorrell TC (2009) Rapid etiological classification of meningitis by NMR spectroscopy based on metabolite profiles and host response. PLoS One 4(4):e5328
76. Pears MR, Salek RM, Palmer DN, Kay GW, Mortishire-Smith RJ, Griffin JL (2007) Metabolomic investigation of CLN6 neuronal ceroid lipofuscinosis in affected South Hampshire sheep. J Neurosci Res 85(15):3494-3504
77. Verwaest KA, Vu TN, Laukens K, Clemens LE, Nguyen HP, Van Gasse B, Martins JC, Van Der Linden A, Dommisse R (2011) (1)H NMR based metabolomics of CSF and blood serum: a metabolic profile for a transgenic rat model of Huntington disease. Biochim Biophys Acta 1812(11):1371-1379
78. Sinclair AJ, Viant MR, Ball AK, Burdon MA, Walker EA, Stewart PM, Rauz S, Young SP (2010) NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases-a diagnostic tool? NMR Biomed 23(2):123-132
79. Kawashima H, Oguchi M, Ioi H, Amaha M, Yamanaka G, Kashiwagi Y, Takekuma K, Yamazaki Y, Hoshika A, Watanabe Y (2006) Primary biomarkers in cerebral spinal fluid obtained from patients with influenza-associated encephalopathy analyzed by metabolomics. Int J Neurosci 116(8):927-936
80. Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, Wägele B, Altmaier E, CARDIoGRAM, Deloukas P, Erdmann J, Grundberg E, Hammond CJ, de Angelis MH, Kastenmüller G, Köttgen A, Kronenberg F, Mangino M, Meisinger C, Meitinger T, Mewes HW, Milburn MV, Prehn C, Raffler J, Ried JS, Römisch-Margl W, Samani NJ, Small KS, Wichmann HE, Zhai G, Illig T, Spector TD, Adamski J, Soranzo N, Gieger C, Assimes TL, Deloukas P, Erdmann J, Holm H, Kathiresan S, König IR, McPherson R, Reilly MP, Roberts R, Samani NJ, Schunkert H, Stewart AF (2011) Human metabolic individuality in biomedical and pharmaceutical research. Nature 477:54-60